Upregulation of transforming growth factor-β1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity

[1]  C. Gajdusek,et al.  Basic fibroblast growth factor and transforming growth factor beta‐1: Synergistic mediators of angiogenesis in vitro , 1993, Journal of cellular physiology.

[2]  I. K. Cohen,et al.  Morphological and immunochemical differences between keloid and hypertrophic scar. , 1994, The American journal of pathology.

[3]  G. Panayi,et al.  Tumour necrosis factor‐alpha (TNF‐α) enhances lymphocyte migration into rheumatoid synovial tissue transplanted into severe combined immunodeficient (SCID) mice , 2000, Clinical and experimental immunology.

[4]  B. Berse,et al.  Hypoxia augments cytokine (transforming growth factor‐beta (TGF‐β) and IL‐1)‐induced vascular endothelial growth factor secretion by human synovial fibroblasts , 1999, Clinical and experimental immunology.

[5]  H. Namba,et al.  Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts. , 1999, The American journal of pathology.

[6]  M. Robson,et al.  An in vivo model of human proliferative scar. , 1998, The Journal of surgical research.

[7]  M. Longaker,et al.  Hypoxia upregulates VEGF production in keloid fibroblasts. , 1999, Annals of plastic surgery.

[8]  L. L. Pu,et al.  Exogenous transforming growth factor beta(2) modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats. , 1999, The Journal of surgical research.

[9]  Bart Landuyt,et al.  Vascular Endothelial Growth Factor and Angiogenesis , 2004, Pharmacological Reviews.

[10]  Kischer Cw,et al.  The microvessels in hypertrophic scars, keloids and related lesions: a review. , 1992 .

[11]  W. Garner,et al.  Fibroproliferative scars. , 2003, Clinics in plastic surgery.

[12]  M. Goumans,et al.  Balancing the activation state of the endothelium via two distinct TGF‐β type I receptors , 2002, The EMBO journal.

[13]  K. Alitalo,et al.  Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. , 1994, The Journal of biological chemistry.

[14]  C. Tei,et al.  Apolipoprotein J/Clusterin Is Induced in Vascular Smooth Muscle Cells After Vascular Injury , 2001, Circulation.

[15]  M. Longaker,et al.  Transforming growth factor- b 1 modulates the expression of vascular endothelial growth factor by osteoblasts , 1999 .

[16]  D. Ann,et al.  Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts. , 2003, The Journal of investigative dermatology.

[17]  R. Timpl,et al.  Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-beta 1 mRNA. , 1991, The Journal of investigative dermatology.

[18]  M Kon,et al.  On the nature of hypertrophic scars and keloids: a review. , 1999, Plastic and reconstructive surgery.

[19]  E. Brogi,et al.  Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. , 1994, Circulation.

[20]  Rakesh K Jain,et al.  Molecular regulation of vessel maturation , 2003, Nature Medicine.

[21]  D. Ann,et al.  Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts. , 2004, American journal of physiology. Cell physiology.

[22]  G. Lemperle,et al.  Elevated Levels of Testosterone Receptors in Keloid Tissue: An Experimental Investigation , 1997, Plastic and reconstructive surgery.

[23]  C. Kischer,et al.  Implants of hypertrophic scars and keloids into the nude (athymic) mouse: viability and morphology. , 1989, The Journal of trauma.

[24]  I. K. Cohen,et al.  The effect of TGF-beta on keloid fibroblast proliferation and collagen synthesis. , 1996, Plastic and reconstructive surgery.

[25]  D. Messadi,et al.  Elevated Vascular Endothelial Growth Factor in Keloids: Relevance to Tissue Fibrosis , 2004, Cells Tissues Organs.

[26]  R. Tarnuzzer,et al.  Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels , 1997, Nature Medicine.

[27]  M. Longaker,et al.  Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. , 1999, Annals of plastic surgery.

[28]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[29]  M. Longaker,et al.  Complex epithelial–mesenchymal interactions modulate transforming growth factor‐β expression in keloid‐derived cells , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[30]  P. Shenefelt,et al.  Keloids and hypertrophic scars. , 1999, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[31]  L. F. Fajardo,et al.  Transforming growth factor beta1 induces angiogenesis in vivo with a threshold pattern. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[32]  C. Kischer,et al.  Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. , 1982, Human pathology.

[33]  L. Ellis,et al.  Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  A. Vladutiu,et al.  The severe combined immunodeficient (SCID) mouse as a model for the study of autoimmune diseases , 1993, Clinical and experimental immunology.

[35]  L. Orci,et al.  Biphasic Effect of Transforming Growth Factor-β1 on in Vitro Angiogenesis , 1993 .

[36]  D. Willoughby,et al.  Apoptosis, necrosis, and proliferation: possible implications in the etiology of keloids. , 1996, The American journal of pathology.

[37]  J. Arbiser,et al.  Keloids demonstrate high-level epidermal expression of vascular endothelial growth factor. , 2004, Journal of the American Academy of Dermatology.

[38]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[39]  T. Tuan,et al.  The molecular basis of keloid and hypertrophic scar formation. , 1998, Molecular medicine today.

[40]  D H Wright,et al.  Angiogenesis in pathological and surgical scars. , 1998, Human pathology.

[41]  J. Bardach,et al.  Implantation of human keloid into athymic mice , 1987, The Laryngoscope.

[42]  R. Hamdy,et al.  Mechanism of transforming growth factor-L 1-induced expression of vascular endothelial growth factor in murine osteoblastic MC 3 T 3E 1 cells , 2000 .

[43]  U. Renner,et al.  Transforming Growth Factor-Stimulates Vascular Endothelial Growth Factor Production by Folliculostellate Pituitary Cells , 2002 .